Welcome back, everyone. We hope your weekend was refreshing and put to good use. Now, of course, the routine returns, although this is a short week on this side of the pond. Nonetheless, meetings and deadlines loom, if only for a little while. So please join us as we brew the mandatory cup of stimulation and peruse the news of the world. Hope your day goes well and stay in touch...
Bayer & Regeneron Eye Drugs Show Good Results (Bloomberg News)
Genzyme Considers New Sanofi Deal Structure (TheStreet)
FDA Approves 2nd Human Study Of Embryonic Stem Cells (Associated Press)
Merck Wins Fosamax Trial (The New York Times)
VR Labs To Build HQ In Florida (Fort Myers News-Press)
Advair Poses Generic Hurdles (The Wall Street Journal)